Pancreatic Cancer Research

ResearcherUniversity of MissouriNo recent work listed

Jing Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7250-0520; OpenAlex author ID A5079611254. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 3

  1. Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy. Co-author DOI 10.1016/j.tranon.2021.101262↗
  2. MiR-487a-3p suppresses the malignant development of pancreatic cancer by targeting SMAD7. Co-author DOI 10.1016/j.yexmp.2020.104489↗
  3. Protease-activated receptor 2 agonist increases cell proliferation and invasion of human pancreatic cancer cells. Last author DOI 10.3892/etm.2014.2052↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianing Xi · 1 shared paper, 2020 · strength 0.16
  2. Chiswili Yves Chabu · 1 shared paper, 2022 · strength 0.15
  3. Eric T. Kimchi · 1 shared paper, 2022 · strength 0.15
  4. Guangfu Li · 1 shared paper, 2022 · strength 0.15
  5. Jussuf T. Kaifi · 1 shared paper, 2022 · strength 0.15
  6. Liqun Xie · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.